The Massachusetts Life Sciences Center (MLSC) Biobank Program is designed to break these barriers by establishing disease-specific, accessible biobanks sourced from diverse patient populations across Massachusetts.
Donor Name: Massachusetts Life Sciences Center
State: Massachusetts
County: All Counties
Type of Grant: Grant
Deadline: 10/03/2025
Size of the Grant: Not Available
Grant Duration: Grant Duration Not Mentioned
Details:
The life science ecosystem thrives on access to patient samples and data for breakthrough, patient-centric research. Yet, many researchers face significant barriers, including institutional restrictions and inconsistent protocols.
By tackling patient sample and data access challenges, this initiative empowers startups, mid-sized companies, pharmaceutical firms, and translational researchers to drive innovation in diagnostic and therapeutic development.
Based on the ecosystem-wide Phase 1 survey, they have identified colorectal cancer and Alzheimer’s disease as the disease areas of focus for the first round. Partnering with institutions statewide, the goal is to create a broadly usable biobank that benefits both non-profit and for-profit institutions seeking high-quality patient samples and data.
Key Focus Areas
- Standardized patient sample collection, storage, and analysis
- Accessible biospecimens (biopsy, blood, saliva, urine, tissue, etc.)
- Improved data-sharing frameworks to foster cross-institutional collaboration
- Development of patient avatars and experimental models to enhance drug discovery
- Equitable inclusion of diverse patient populations to improve health outcomes with all patients in mind
- Longitudinal sample collection and data generation.
Disease Areas for 2025-2026
- Colorectal Cancer
- Alzheimer’s Disease
Eligibility Criteria
The Massachusetts Life Sciences Center invite academic medical centers (AMCs) and other non-profit patient care centers in Massachusetts to serve as centers for sample and medical data collection for Colorectal Cancer and Alzheimer’s Disease.
For more information, visit MLSC.
